Supplements for insulin resistance: what actually has data

Berberine, inositol, magnesium, omega-3, vitamin D and chromium, measured against what the trials found and against the interventions that outperform all of them.

Key takeaways

  • Berberine has the most consistent glycemic effect in the category, with meta-analyses reporting reductions in fasting glucose and HbA1c, mostly from small trials of variable quality.
  • Myo-inositol has reasonable evidence for insulin sensitivity in polycystic ovary syndrome specifically.
  • Magnesium repletion improves insulin sensitivity measures in people who are low. In people who are not low, it does not.
  • Chromium, cinnamon and bitter melon have weak or inconsistent trial results despite heavy marketing.
  • No supplement in this category matches what the Diabetes Prevention Program achieved with lifestyle change, a 58 percent reduction in progression to diabetes over 2.8 years.

Insulin resistance responds to supplements more than most conditions, which is why the category is crowded.

It also responds far more to training, sleep, weight loss and, where appropriate, prescription therapy. The supplements are an addition to that, not an alternative.

Set the benchmark first

The Diabetes Prevention Program randomized 3,234 adults with impaired glucose tolerance to intensive lifestyle change, metformin or placebo. Lifestyle change reduced progression to diabetes by 58 percent and metformin by 31 percent over an average of 2.8 years.

That is the number every supplement in this category is implicitly competing with, and none of them have been tested against it. Reading the supplement literature without that benchmark in view is how people end up with an expensive cabinet and an unchanged HOMA-IR.

Berberine

Berberine is a plant alkaloid that activates AMPK and alters gut microbial metabolism. Meta-analyses of randomized trials report reductions in fasting glucose, HbA1c and insulin resistance measures, with some trials showing effects in the range of oral glycemic medications.

The honest caveats: most trials were small, many were conducted in a single region, and quality was inconsistent. Bioavailability is poor, gastrointestinal side effects are common, and berberine inhibits CYP3A4, which means real interaction potential with prescription medications. It is not a benign addition to an unreviewed medication list.

Inositol

Myo-inositol functions as a second messenger in insulin signaling. In polycystic ovary syndrome, randomized trials and meta-analyses report improvements in insulin sensitivity measures and ovulatory function, usually at 2 to 4 g daily, often with D-chiro-inositol in a 40 to 1 ratio.

Outside PCOS, the evidence thins considerably. This is a case where a supplement has a defined population rather than a general one.

Magnesium, omega-3 and vitamin D

Magnesium is a cofactor in insulin signaling, and low intake is associated with higher diabetes incidence in cohort studies. Trials of supplementation improve insulin sensitivity measures mainly in people who were deficient or hypomagnesemic to begin with.

Omega-3 improves triglycerides substantially and the triglyceride to HDL ratio with it, which is why it often appears on a metabolic plan. Its direct effect on insulin sensitivity is small.

Vitamin D is the clearest example of the deficiency principle. D2d found no significant benefit for diabetes prevention in a largely sufficient population, while correcting genuine deficiency remains worthwhile for other reasons.

The ones that underperform their marketing

  • Chromium picolinate: meta-analyses report small and inconsistent glycemic effects, with the clearest results in poorly controlled diabetes rather than insulin resistance.
  • Cinnamon: trial results conflict, extracts vary widely, and cassia cinnamon contains coumarin at levels that matter with daily use.
  • Bitter melon, gymnema and fenugreek: small trials, heterogeneous preparations, no reliable effect size.
  • Alpha lipoic acid: better evidence for diabetic neuropathy symptoms than for insulin resistance itself.

Where this fits with what we do

Insulin resistance is measurable, which makes it one of the more satisfying things to work on. Fasting insulin and glucose give you HOMA-IR, HbA1c gives you a three month average, and the triglyceride to HDL ratio is a useful proxy that comes free with a standard lipid panel.

Because it is measurable, supplement decisions do not have to be guesses. Where a provider in our network is involved, they can review a supplement such as berberine against your medication list before it is added.

What this means for you

Measure first with fasting insulin, glucose, HbA1c and a lipid panel. Correct measured deficiencies, consider berberine with a provider reviewing your medications, and put the majority of the effort into training, sleep and body composition, because that is where the large effects are.

Therapies discussed here

References

  1. Knowler WC, et al., reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin (Diabetes Prevention Program), New England Journal of Medicine, 2002
  2. Lan J, et al., meta-analysis of the effect of berberine on glucose and lipid metabolism, Journal of Ethnopharmacology, 2015
  3. Unfer V, et al., myo-inositol effects in women with PCOS, systematic review of randomized controlled trials, Endocrine Connections, 2017
  4. Veronese N, et al., effect of magnesium supplementation on glucose metabolism, systematic review and meta-analysis, European Journal of Clinical Nutrition, 2016
  5. Pittas AG, et al., vitamin D supplementation and prevention of type 2 diabetes (D2d), New England Journal of Medicine, 2019
  6. Matthews DR, et al., homeostasis model assessment, Diabetologia, 1985

More in Supplements